VM
Vikas Mohanlal Vishnoi
About Vikas Mohanlal Vishnoi
Data last updated:
Vikas Mohanlal Vishnoi is a Director at Glanza Lifesciences Private Limited (since 2022). The companies operate in Pharma and Environment. Earlier, Vikas Mohanlal Vishnoi was a Director at Maximus Envirotech Private Limited (2016).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 02 Jun 2022 | 2022 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 16 Jun 2016 | 2016 | ₹4.37 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Vikas Mohanlal Vishnoi
| Name | DIN | Company | Designation |
|---|---|---|---|
| Mohanlal Dhannaram Bishnoi | 07483720 | Glanza Lifesciences Private Limited | Director |
| Shanti Mohanlal Bishnoi | 09629346 | Glanza Lifesciences Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vikas Mohanlal Vishnoi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vikas Mohanlal Vishnoi
Vikas Mohanlal Vishnoi currently holds 1 directorship: Glanza Lifesciences Private Limited (Director, since 02 Jun 2022).
Vikas Mohanlal Vishnoi was first appointed on 16 Jun 2016 as Director at Maximus Envirotech Private Limited. The most recent appointment on record is 02 Jun 2022 at Glanza Lifesciences Private Limited.
Vikas Mohanlal Vishnoi held 1 earlier board appointment: Maximus Envirotech Private Limited (Director, 16 Jun 2016 to 27 Jun 2016).
The current boards of Vikas Mohanlal Vishnoi's companies include Mohanlal Dhannaram Bishnoi (Glanza Lifesciences Private Limited), Shanti Mohanlal Bishnoi (Glanza Lifesciences Private Limited).